Gary Schlichter
Pediatrics · Murray, UTNPI 1326031246
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 66 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 17.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $260 and has fallen 69.3% since, to $80 in 2025.
Across 66 payments — averaging $18.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$212
- Pfizer$181
- Sanofi Pasteur Inc.$116
- Corium, LLC$103
- Takeda Pharmaceuticals U.S.A., Inc.$98
- Tris Pharma Inc$94
- plus $424 from 14 others
Across 88 payments — averaging $8400.28 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sanofi Pasteur Inc.$472K
- GSK$149K
- Perrigo Company PLC$57K
- AstraZeneca$55K
- Astrazeneca UK Limited$7K
What the payments were for
- Food & beverage$1,229100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 13 | $212 |
| Pfizer | 11 | $181 |
| Sanofi Pasteur Inc. | 6 | $116 |
| Corium, LLC | 5 | $103 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $98 |
| Tris Pharma Inc | 3 | $94 |
| Cranial Technologies, Inc | 4 | $76 |
| Sobi, Inc | 3 | $72 |
| Ironshore Pharmaceuticals Inc. | 3 | $43 |
| Seqirus USA Inc | 2 | $31 |
| GSK | 2 | $27 |
| Ipsen Biopharmaceuticals, Inc | 1 | $25 |
| AstraZeneca | 1 | $24 |
| Biomerieux Inc | 1 | $24 |
| Quidel Corporation | 1 | $21 |
| Ultragenyx Pharmaceutical Inc. | 1 | $20 |
| Neurelis, Inc. | 1 | $19 |
| Azurity Pharmaceuticals, Inc. | 1 | $15 |
| Adlon Therapeutics L.p. | 1 | $14 |
| Supernus Pharmaceuticals, Inc. | 1 | $13 |
How this compares
$1,229 in reported general payments places this provider in the 80th percentile of 439 pediatrics providers in Utah.
Other pediatrics in Murray
- David JubelirerMurray$2K
- David NuttallAmerican Fork$307K
- Mari LuceLayton$289K
- Brian ShayotaSalt Lake City$93K
- Rodney PollaryLehi$56K
- Laura SavageProvo$49K
- Ashley AndrewsSalt Lake City$31K
- Samantha BostromClinton$18K
- Michael JensenSalt Lake City$18K
- Mary TiptonWest Jordan$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.